Ocular Tolerance and Intraocular Pressure (IOP) Effects of Zylet Versus Tobradex
Clinical trial NCT00532961 · COMPLETED
Trial details
- NCT number
- NCT00532961
- Sponsor
- Bausch & Lomb Incorporated
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2005-02-01
- Primary completion
- 2005-04-01
- Enrollment
- 310
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.